Clinical Application of Total Body PET/CT
Dr. Hongcheng Shi, PhD
12:30 – 1:15 p.m. in Moss Auditorium
June 5, 2024
Via WebEx
Total body PET with 194cm AFOV has higher sensitivity. It could realize low activity (even 0.37MBq/kg) scan, fast scan, whole body dynamic scan and so on to serve patient better than conventional PET with 15-30 cm AFOV.
To view previous Grand Rounds lectures, click here.
About the Lecturer — Dr. Hongcheng Shi, PhD
Professor Hongcheng Shi graduated from Huashan Medical College in 1988 and completed his residency in Radiology in 1991. In 1994, he finished a three-year postgraduate research training and became an attending physician and Associate Director in Radiology at the General Hospital of Fushun Coal Mining Bureau, Fushun, China. In 1998, Dr. Shi received his PhD in Clinical Medicine from Fudan University. Since then, he has been a Professor and the Chair of the Department of Nuclear Medicine at Zhongshan Hospital, Fudan University, one of the top five Universities in China. He also serves as the Director of the Research Institute of Nuclear Medicine at Fudan University and the Associate Director of the Medical Imaging Institute in Shanghai. Under his leadership, the Department of Nuclear Medicine has grown from a team of about 10 staff members to one of the largest and top nuclear medicine departments in China, now comprising over 60 staff members. The department covers all areas of clinical nuclear medicine, including SPECT/CT, PET/CT, PET/MRI, radionuclide therapy, radiotheranostics, and in the near future, innovative boron neutron capture therapy.
Dr. Shi’s research encompasses combined imaging techniques such as SPECT/CT, PET/CT, and PET/MRI in oncology, neurological disorders, and cardiovascular disease. Since 2007, his group has received substantial support from the National Natural Science Foundation of China and the National Key Research and Development Program of the Ministry of Science and Technology of China. Dr. Shi has published over 200 peer-reviewed papers as the first author or corresponding author and authored several textbooks, including “Nuclear Cardiology,” “Procedure Guideline and Clinical Application of SPECT/Diagnostic CT,” “PET/CT Clinical Evidence-Based Practice and Procedure Guidance,” and the recent “Total-Body PET/CT: Its Prospective Clinical Application.” He has also completed near 20 clinical trials.
Dr. Shi has served on the expert panel and grant review committee for the National Natural Science Foundation and the Ministry of Health of China, and for the Accreditation Council for Postgraduate Education, Ministry of Education, China. Since 2014, Dr. Shi has been on the Board of Directors for the Chinese Society of Nuclear Medicine and Molecular Imaging, serving as Vice President from 2017 to 2023, and is the President-elect for the term from 2023 to 2026. Dr. Shi has received numerous awards, including the prestigious “Honorary Fellowship” from the American College of Nuclear Medicine in 2017 and the Special Contribution Award from the President of the American Society of Nuclear Medicine and Molecular Imaging in 2020.
Notably, Dr. Shi is the first physician and pioneer in the clinical research and application of the transformative total-body PET/CT technology worldwide. His team has performed this transformative imaging on more than 35,000 patients over the past five years and has published over 40 papers specifically on this innovative scanner, many of which have become standard guidelines for hospitals globally.
Comments